The latest Health Canada stats continue to show the Canadian cannabis market is flooded with supply while most companies are set to further ramp up production capacity and output. Aurora Cannabis ( ACB ) has long promoted a leadership position in building production capacity despite the expected limitations to the market demand in Canada and around the world. With the stock below $4, investors will want to see the company lead the market in constraining supplies in order to focus on positive cash flows.